Lubos J.
- Country
- Czechia
- Department
- Psychiatry
Research Overview
- Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Mebufotenin (GH001) Efficacy and Safety in Treatment-Resistant Depression Patients
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study
Data & Insights
Has run more than one trial at 319 of 625 partner sites.
Specializations
Mood Disorders
This investigator specializes in various forms of major depressive disorder, including cases with treatment resistance and those complicated by anhedonia and insomnia symptoms. Their research encompasses both standard depression treatments and adjunctive therapeutic approaches.
- Treatment-resistant depression
- Depression with anhedonia
- Adjunctive antidepressant therapy
Anxiety and Neurological Conditions
The investigator focuses on therapeutic interventions for generalized anxiety disorder and various types of migraine conditions, including specialized research in menstrual migraine prevention and chronic migraine management.
- Anxiety disorders
- Chronic and episodic migraine
- Menstrual migraine
Neurodegenerative Disorders
Research activities center on Alzheimer's disease and related conditions, including early-stage interventions and management of associated psychosis. The investigator also studies cognitive disorders and tardive dyskinesia.
- Early Alzheimer's disease
- Alzheimer's with inflammation markers
- Cognitive impairment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.